SPRY icon

ARS Pharmaceuticals

64 hedge funds and large institutions have $73.3M invested in ARS Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 14 increasing their positions, 23 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

28% less call options, than puts

Call options by funds: $2.92M | Put options by funds: $4.07M

39% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 23

Holders
64
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.92M
Puts
$4.07M
Net Calls
Net Calls Change

Top Sellers

1 -$10.4M
2 -$3.81M
3 -$1.22M
4
State Street
State Street
Massachusetts
-$1.17M
5
Two Sigma Investments
Two Sigma Investments
New York
-$880K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$15.8M
2
$8.1M
3
$6.54M
4
$5.88M
5
$4.48M
6
$4.18M
7
$3M
8
$2.44M
9
$2.33M
10
$1.93M
11
$1.81M
12
$1.45M
13
$1.35M
14
$1.03M
15
$1.01M
16
$982K
17
$948K
18
$887K
19
$820K
20
$721K
21
$705K
22
$643K
23
$563K
24
$523K
25
$452K